Search
for
Sort by
Research 181–210 of 1000+
- Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life
- CONTRACEPTION AND THE SKIN
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Utilization of Contraception Methods and Side Effects among Women Attending the Maternal and Child Healthcare Centers in Mukalla City, Hadhramout, Yemen
- Management of women with hirsutism in Kosovo
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- SAT-210 When Acne, Hirsutism and Menstrual Irregularities Are More Than PCOS
- Polycystic ovarian syndrome
- Steroid Hormones of Reproduction and Sexual Development
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Androgenisierung
- Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study
- [Hirsutism].
- [Differentiated application of oral contraceptives basing on the different side effects of synthetic progestins (author's transl)].
- Polycystic ovary syndrome in North America
- Treatment of hirsutism and acne in hyperandrogenism
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Melasma and other skin manifestations or oral contraceptives.
- 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
- A Literature Review of the Effects of PCOS on Cardiovascular Health
- Polycystic ovary syndrome: Diagnosis and management
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
- Porphyria Cutanea Tarda – a Case Report
- Effect of contraceptives on the skin.
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline